Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BCL2L1 | Q07817 | 18/20 | 0.83 |
| ▸ | BCL2 | P10415 | 16/20 | 0.83 |
| ▸ | BAD | Q92934 | 4/20 | 0.83 |
| ▸ | BCL2L2 | Q92843 | 2/20 | 0.83 |
| ▸ | BCL2L11 | O43521 | 1/20 | 0.83 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.83 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.83 |
| ▸ | ASPH | Q12797 | 1/20 | 0.83 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2081950 | 1.00 | BCL2L1 (0.83) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL1627943 | 0.97 | BCL2L1 (0.77) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL1957284 | 0.97 | BCL2L1 (0.77) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL19419610 | 0.96 | BCL2L1 (0.78) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL2081967 | 0.96 | BCL2L1 (0.78) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL30405052 | 0.94 | BCL2L1 (0.74) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL4733622 | 0.93 | BCL2L1 (0.84) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL19419613 | 0.93 | BCL2L1 (0.84) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL19424184 | 0.93 | BCL2L1 (0.84) | BCL2L1BCL2BADBCL2L2BCL2L11 | |
| SCHEMBL1958008 | 0.93 | BCL2L1 (0.84) | BCL2L1BCL2BADBCL2L2BCL2L11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008064116-A2 | METHOD OF PREVENTING OR TREATING ORGAN, HEMATOPOIETIC STEM CELL OR BONE MARROW TRANSPLANT REJECTION | ABBOTT LABORATORIES (US) | 2008-05-29 | — | — | WO | disclosed |